Catalyst Pharmaceuticals, Inc. CPRX
31.49 USD 0.00 (+0.00%)
Jul 15, 2026, 9:30 AM EDT
31.49 Day range 31.49
52-week range unavailable
- YTD
- +34.92%
- 1 year
- +43.86%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 588.99M | 491.73M | 398.20M | 214.20M | 140.83M | |
| 501.74M | 422.89M | 346.24M | 179.81M | 118.95M | |
| 257.78M | 195.12M | 86.81M | 101.84M | 52.38M | |
| 214.33M | 163.89M | 71.41M | 83.08M | 39.48M | |
| 1.68 | 1.31 | 0.63 | 0.75 | 0.37 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 709.17M | 517.55M | 137.64M | 298.39M | 171.45M | |
| 1.10B | 851.41M | 470.11M | 375.63M | 237.79M | |
| 149.71M | 123.78M | 82.23M | 75.21M | 30.96M | |
| 2.35M | 2.79M | 3.19M | 3.56M | 3.89M | |
| 954.27M | 727.63M | 387.88M | 300.42M | 206.83M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 208.67M | 239.81M | 143.60M | 116.05M | 60.37M | |
| -58.00K | -556.00K | -293.50M | 9.21M | -11.02M | |
| -16.99M | 140.66M | -10.86M | 1.69M | -8.14M | |
| -58.00K | -556.00K | -231.00K | -29.00K | -1.02M | |
| 191.62M | 379.92M | -160.76M | 126.95M | 41.21M |